
无数据
无数据
无数据
| CAS Number | 129-56-6 |
| Catalog Number | AG000YRD(AGN-PC-0JK8LA) |
| Chemical Name | 1,9-Pyrazoloanthrone |
| EC Number | 204-955-6 |
| IUPAC Name | 14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one |
| InChI | InChI=1S/C14H8N2O/c17-14-9-5-2-1-4-8(9)13-12-10(14)6-3-7-11(12)15-16-13/h1-7H,(H,15,16) |
| InChI Key | ACPOUJIDANTYHO-UHFFFAOYSA-N |
| MDL Number | MFCD00022289 |
| Molecular Formula | C14H8N2O |
| Molecular Weight | 220.2261 |
| NSC Number | 75890 |
| SMILES | N=1NC2=C3C1C1=CC=CC=C1C(C3=CC=C2)=O |
| UNII | 1TW30Y2766 |
| Synonyms | 1,9-pyrazoloanthrone,
2h-dibenzo(cd,g)indazol-6-one,
anthra(1,9-cd)pyrazol-6(2H)-one,
NSC-75890,
NSC75890,
pyrazolanthrone,
SP600125,
129-56-6,
1,9-Pyrazoloanthrone,
SP600125,
Pyrazolanthrone,
Dibenzo[cd,g]indazol-6(2H)-one,
Pyrazoleanthrone,
SP 600125,
Anthra[1,9-cd]pyrazol-6(2H)-one,
Anthra-1,9-pyrazol-6-none,
SP-600125,
JNK Inhibitor II,
2H-Dibenzo[cd,g]indazol-6-one,
C.I. 70300,
SAPK Inhibitor II,
NSC 75890,
1pmv,
UNII-1TW30Y2766,
ANTHRA(1,9-cd)PYRAZOL-6(2H)-ONE,
NSC75890,
EINECS 204-955-6,
2,6-DIHYDROANTHRA/1,9-CD/PYRAZOL-6-ONE,
BRN 0746890,
CHEMBL7064,
MLS002693964,
CHEBI:90695,
ACPOUJIDANTYHO-UHFFFAOYSA-N,
InSolution™ JNK Inhibitor II,
1TW30Y2766,
NCGC00015958-03,
14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-8-one,
SMR000015440,
SR-01000075840,
2zmd,
SAPK Inhibitor I,
NSC-75890,
1 9-pyrazoleanthrone,
Kinome_3844,
Tocris-1496,
AC1Q6DQN,
BiomolKI_000068,
timtec-bb sbb000595,
Lopac-S-5567,
BiomolKI2_000072,
AC1L1R5Y,
AC1Q6DR1,
AC1Q6DR2,
cid_8515,
DSSTox_CID_20525,
DSSTox_RID_79502,
CBiol_002049,
DSSTox_GSID_40525,
Lopac0_000473,
BMK1-G8,
BSPBio_001066,
ChemBiol10705 Compound 4,
KBioGR_000406,
KBioSS_000406,
JMC517015 Compound 2,
KSC516G2D,
MLS002153267,
MLS006011577,
SCHEMBL170980,
anthra[1,9-cd]pyrazol-6-one,
GTPL5273,
CHEMBL1725279,
DTXSID2040525,
SCHEMBL15583517,
BCBcMAP01_000053,
BDBM16018,
CTK4B6321,
KBio2_000406,
KBio2_002974,
KBio2_005542,
KBio3_000771,
KBio3_000772,
Bio1_000335,
Bio1_000824,
Bio1_001313,
Bio2_000373,
Bio2_000853,
HMS1362F07,
HMS1667K13,
HMS1792F07,
HMS1990F07,
HMS2250C03,
HMS3229I16,
HMS3261O08,
HMS3267P06,
HMS3403F07,
HMS3654P10,
HMS3676F05,
ALBB-024051,
Anthra[1,9cd]pyrazol-6(2H)-one,
BCP05457,
c.i.70300,
EX-A1998,
Tox21_110267,
Tox21_500473,
Anthra[1-9-cd]pyrazol-6(2H)-one,
ANW-68872,
BDBM50024294,
BDBM50433916,
CCG-47500,
Dibenzo[cd,g]indazol-6(2H)-one #,
HSCI1_000136,
MFCD00022289,
s1460,
SBB000595,
ZINC96298875,
AKOS000115584,
Anthrapyrazolone; 1,9-Pyrazoloanthrone,
CCG-100672,
CS-0196,
DB01782,
LP00473,
MCULE-7820194475,
VA10299,
2,6-dihydrodibenzo[cd,g]indazol-6-one,
IDI1_002128,
QTL1_000077,
SMP2_000240,
NCGC00015958-01,
NCGC00015958-02,
NCGC00015958-04,
NCGC00015958-05,
NCGC00015958-06,
NCGC00015958-07,
NCGC00015958-08,
NCGC00025186-01,
NCGC00025186-02,
NCGC00025186-03,
NCGC00025186-04,
NCGC00025186-05,
NCGC00261158-01,
WLN: T C6665 1A P IV OMNJ,
AJ-50631,
AK-57219,
AN-43643,
AS-14374,
BAS 00719687,
BC200202,
CAS-129-56-6,
CJ-11929,
HY-12041,
K914,
LS-20607,
SC-62298,
SMR002530644,
ST018684,
TC-157617,
TL8000704,
EU-0100473,
FT-0607068,
ST24046474,
SW218106-2,
EN300-02083,
Anthra[1,9-cd]pyrazol-6(2H)-one & Z-100,
K00068,
S 5567,
SP600125, >=98% (HPLC),
AB00075935-01,
SP 600125 & Z-100,
129S566,
SR-01000075840-1,
SR-01000075840-2,
SR-01000075840-4,
SR-01000075840-6,
SR-01000637108-1,
W-108360,
BRD-K01567962-001-04-0,
BRD-K01567962-001-06-5,
BRD-K01567962-001-08-1,
BRD-K01567962-001-22-2,
Z56785477,
F1414-1245,
SP600125, 129-56-6,
14,15-diazatetracyclo[7.6.1.0(2),.0(1)(3),(1)]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one,
14,15-diazatetracyclo[7.6.1.0;{2,7}.0;{13,16}]hexadeca-1(15),2(7),3,5,9(16),10,12-heptaen-8-one,
14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2(7),3,5,9(16),10,12-heptaen-8-one,
Anthrapyrazolone,
[?]one,
D00JXM,
D02PVB,
C14H8N2O,
Color Index No. 70300,
Color Index Number 70300,
cc-622,
Colour Index No. 70300,
Colour Index Number 70300,
2h-dibenzo(cd,g)indazol-6-one,
dibenz[cd,g]indazol-6(2h)-one,
CID8515,
C14-H8-N2-O,
CI 70300,
A2548,
A4604,
A10860,
C432165,
Anthra[1,9-cd]pyrazol-6(2H)-one, 98% - 100MG 100mg,
189681-71-8,
7664-93-9,
|
| Complexity | 343 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 220.064g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 17 |
| Hydrogen Bond Acceptor Count | 2 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 220.231g/mol |
| Monoisotopic Mass | 220.064g/mol |
| Rotatable Bond Count | 0 |
| Topological Polar Surface Area | 45.8A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.7 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

